Jundishapur Journal of Microbiology

Published by: Kowsar

Assessment of the Human Cytomegalovirus UL97 Gene for Identification of Resistance to Ganciclovir in Iranian Immunosuppressed Patients

Hossein Keyvani 1 , 2 , Sedigheh Taghinezhad Saroukalaei 2 , 3 and Amir Hossein Mohseni 2 , 3 , *
Authors Information
1 School of Medicine, Iran University of Medical Sciences, Tehran, IR Iran
2 Research and Development Department, Keyvan Virology Specialty Laboratory (KVSL), Tehran, IR Iran
3 Department of Microbiology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 01, 2016, 9 (5); e31733
  • Published Online: May 29, 2016
  • Article Type: Research Article
  • Received: July 22, 2015
  • Revised: April 12, 2016
  • Accepted: April 23, 2016
  • DOI: 10.5812/jjm.31733

To Cite: Keyvani H, Taghinezhad Saroukalaei S, Mohseni A H. Assessment of the Human Cytomegalovirus UL97 Gene for Identification of Resistance to Ganciclovir in Iranian Immunosuppressed Patients, Jundishapur J Microbiol. 2016 ; 9(5):e31733. doi: 10.5812/jjm.31733.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): clinical findings, diagnosis, and treatment. Ann Intern Med. 1988; 108(4): 585-94[PubMed]
  • 2. Miller W, Flynn P, McCullough J, Balfour HJ, Goldman A, Haake R, et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood. 1986; 67(4): 1162-7[PubMed]
  • 3. Numata S, Nakamura Y, Imamura Y, Honda J, Momosaki S, Kojiro M. Rapid quantitative analysis of human cytomegalovirus DNA by the real-time polymerase chain reaction method. Arch Pathol Lab Med. 2005; 129(2): 200-4[DOI][PubMed]
  • 4. Boriskin YS, Fuller K, Powles RL, Vipond IB, Rice PS, Booth JC, et al. Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21. 5: a two site evaluation. J Clin Virol. 2002; 24(1-2): 13-23[PubMed]
  • 5. Yun Z, Lewensohn-Fuchs I, Ljungman P, Vahlne A. Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays. Transplantation. 2000; 69(8): 1733-6[PubMed]
  • 6. Sanchez JL, Storch GA. Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol. 2002; 40(7): 2381-6[PubMed]
  • 7. Balfour HJ. Management of cytomegalovirus disease with antiviral drugs. Rev Infect Dis. 1990; 12 Suppl 7-60[PubMed]
  • 8. Lalezari JP, Drew WL, Glutzer E, James C, Miner D, Flaherty J, et al. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis. 1995; 171(4): 788-96[PubMed]
  • 9. Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med. 1997; 126(4): 257-63[PubMed]
  • 10. Reid R, Mar EC, Huang ES, Topal MD. Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. J Biol Chem. 1988; 263(8): 3898-904[PubMed]
  • 11. Hantz S, Garnier-Geoffroy F, Mazeron MC, Garrigue I, Merville P, Mengelle C, et al. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study. J Antimicrob Chemother. 2010; 65(12): 2628-40[DOI][PubMed]
  • 12. Hantz S, Michel D, Fillet AM, Guigonis V, Champier G, Mazeron MC, et al. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient. Antimicrob Agents Chemother. 2005; 49(4): 1580-3[DOI][PubMed]
  • 13. Baldanti F, Silini E, Sarasini A, Talarico CL, Stanat SC, Biron KK, et al. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol. 1995; 69(2): 796-800[PubMed]
  • 14. Baldanti F, Michel D, Simoncini L, Heuschmid M, Zimmermann A, Minisini R, et al. Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system. Antiviral Res. 2002; 54(1): 59-67[PubMed]
  • 15. Baldanti F, Lurain N, Gerna G. Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Hum Immunol. 2004; 65(5): 403-9[DOI][PubMed]
  • 16. Chou S, Waldemer RH, Senters AE, Michels KS, Kemble GW, Miner RC, et al. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir. J Infect Dis. 2002; 185(2): 162-9[DOI][PubMed]
  • 17. Chou S, Meichsner CL. A nine-codon deletion mutation in the cytomegalovirus UL97 phosphotransferase gene confers resistance to ganciclovir. Antimicrob Agents Chemother. 2000; 44(1): 183-5[PubMed]
  • 18. Alain S, Honderlick P, Grenet D, Stern M, Vadam C, Sanson-Le Pors MJ, et al. Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient. Transplantation. 1997; 63(10): 1533-6[PubMed]
  • 19. Chou S, Marousek G, Parenti DM, Gordon SM, LaVoy AG, Ross JG, et al. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. J Infect Dis. 1998; 178(2): 526-30[PubMed]
  • 20. Hanson MN, Preheim LC, Chou S, Talarico CL, Biron KK, Erice A. Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob Agents Chemother. 1995; 39(5): 1204-5[PubMed]
  • 21. Wolf DG, Yaniv I, Honigman A, Kassis I, Schonfeld T, Ashkenazi S. Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency. J Infect Dis. 1998; 178(2): 535-8[PubMed]
  • 22. Wolf DG, Smith IL, Lee DJ, Freeman WR, Flores-Aguilar M, Spector SA. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J Clin Invest. 1995; 95(1): 257-63[DOI][PubMed]
  • 23. Wolf DG, Lee DJ, Spector SA. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother. 1995; 39(11): 2552-4[PubMed]
  • 24. Sullivan V, Biron KK, Talarico C, Stanat SC, Davis M, Pozzi LM, et al. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrob Agents Chemother. 1993; 37(1): 19-25[PubMed]
  • 25. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature. 1992; 358(6382): 162-4[DOI][PubMed]
  • 26. Smith IL, Cherrington JM, Jiles RE, Fuller MD, Freeman WR, Spector SA. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J Infect Dis. 1997; 176(1): 69-77[PubMed]
  • 27. Prix L, Maierl J, Jahn G, Hamprecht K. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains. J Clin Virol. 1998; 11(1): 29-37[PubMed]
  • 28. Pepin JM, Simon F, Dussault A, Collin G, Dazza MC, Brun-Vezinet F. Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures. J Clin Microbiol. 1992; 30(11): 2917-20[PubMed]
  • 29. Gerna G, Sarasini A, Percivalle E, Zavattoni M, Baldanti F, Revello MG. Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples. J Clin Microbiol. 1995; 33(3): 738-41[PubMed]
  • 30. Landry ML, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, et al. A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob Agents Chemother. 2000; 44(3): 688-92[PubMed]
  • 31. Liu JB, Zhang Z. Development of SYBR Green I-based real-time PCR assay for detection of drug resistance mutations in cytomegalovirus. J Virol Methods. 2008; 149(1): 129-35[DOI][PubMed]
  • 32. Chakravarti A, Kashyap B, Matlani M. Cytomegalovirus infection: an Indian perspective. Indian J Med Microbiol. 2009; 27(1): 3-11[PubMed]
  • 33. Khansarinejad B, Soleimanjahi H, Mirab Samiee S, Hamidieh AA, Paryan M, Sanahmadi Y. Quantitation of human cytomegalovirus DNA in plasma using an affordable in-house qPCR assay. J Virol Methods. 2012; 183(2): 170-5[DOI][PubMed]
  • 34. Kanaan A, Cour I, Alvarez-Lafuente R, Benedicto M, Culebras E, Prats D, et al. Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients. Int J Antimicrob Agents. 2004; 24(5): 455-62[DOI][PubMed]
  • 35. Benzi F, Vanni I, Cassina G, Ugolotti E, Di Marco E, Cirillo C, et al. Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients. J Clin Virol. 2012; 54(1): 48-55[DOI][PubMed]
  • 36. Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev. 2010; 23(4): 689-712[DOI][PubMed]
  • 37. Gilbert C, Boivin G. Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother. 2005; 49(3): 873-83[DOI][PubMed]
  • 38. Baldanti F, Gerna G. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact. J Antimicrob Chemother. 2003; 52(3): 324-30[DOI][PubMed]
  • 39. Erice A. Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev. 1999; 12(2): 286-97[PubMed]
  • 40. Marfori JE, Exner MM, Marousek GI, Chou S, Drew WL. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients. J Clin Virol. 2007; 38(2): 120-5[DOI][PubMed]
  • 41. Gentry BG, Vollmer LE, Hall ED, Borysko KZ, Zemlicka J, Kamil JP, et al. Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97. Antimicrob Agents Chemother. 2013; 57(9): 4343-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments